1. Home
  2. AVTX vs CATO Comparison

AVTX vs CATO Comparison

Compare AVTX & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • CATO
  • Stock Information
  • Founded
  • AVTX 2011
  • CATO 1946
  • Country
  • AVTX United States
  • CATO United States
  • Employees
  • AVTX N/A
  • CATO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • AVTX Health Care
  • CATO Consumer Discretionary
  • Exchange
  • AVTX Nasdaq
  • CATO Nasdaq
  • Market Cap
  • AVTX 57.4M
  • CATO 55.7M
  • IPO Year
  • AVTX 2015
  • CATO N/A
  • Fundamental
  • Price
  • AVTX $4.13
  • CATO $2.61
  • Analyst Decision
  • AVTX Strong Buy
  • CATO
  • Analyst Count
  • AVTX 6
  • CATO 0
  • Target Price
  • AVTX $34.20
  • CATO N/A
  • AVG Volume (30 Days)
  • AVTX 62.6K
  • CATO 43.9K
  • Earning Date
  • AVTX 05-12-2025
  • CATO 05-22-2025
  • Dividend Yield
  • AVTX N/A
  • CATO 13.28%
  • EPS Growth
  • AVTX N/A
  • CATO N/A
  • EPS
  • AVTX N/A
  • CATO N/A
  • Revenue
  • AVTX $441,000.00
  • CATO $642,949,000.00
  • Revenue This Year
  • AVTX N/A
  • CATO N/A
  • Revenue Next Year
  • AVTX N/A
  • CATO N/A
  • P/E Ratio
  • AVTX $0.59
  • CATO N/A
  • Revenue Growth
  • AVTX N/A
  • CATO N/A
  • 52 Week Low
  • AVTX $3.39
  • CATO $2.19
  • 52 Week High
  • AVTX $16.00
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 45.63
  • CATO 47.99
  • Support Level
  • AVTX $3.43
  • CATO $2.50
  • Resistance Level
  • AVTX $4.03
  • CATO $2.71
  • Average True Range (ATR)
  • AVTX 0.34
  • CATO 0.18
  • MACD
  • AVTX 0.09
  • CATO -0.00
  • Stochastic Oscillator
  • AVTX 70.47
  • CATO 29.44

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: